Hsu DJ - Search Results

1

Threonine fuels glioblastoma through YRDC-mediated codon-biased translational reprogramming.

Wu X, Yuan H, Wu Q, Gao Y, Duan T, Yang K, Huang T, Wang S, Yuan F, Lee D, Taori S, Plute T, Heissel S, Alwaseem H, Isay-Del Viscio M, Molina H, Agnihotri S, Hsu DJ, Zhang N, Rich JN. Wu X, et al. Among authors: hsu dj. Nat Cancer. 2024 Mar 22. doi: 10.1038/s43018-024-00748-7. Online ahead of print. Nat Cancer. 2024. PMID: 38519786

2

Arginine limitation drives a directed codon-dependent DNA sequence evolution response in colorectal cancer cells.

Hsu DJ, Gao J, Yamaguchi N, Pinzaru A, Wu Q, Mandayam N, Liberti M, Heissel S, Alwaseem H, Tavazoie S, Tavazoie SF. Hsu DJ, et al. Sci Adv. 2023 Jan 6;9(1):eade9120. doi: 10.1126/sciadv.ade9120. Epub 2023 Jan 6. Sci Adv. 2023. PMID: 36608131 Free PMC article.

3

Arginine limitation causes a directed DNA sequence evolution response in colorectal cancer cells.

Hsu DJ, Gao J, Yamaguchi N, Pinzaru A, Mandayam N, Liberti M, Heissel S, Alwaseem H, Tavazoie S, Tavazoie SF. Hsu DJ, et al. bioRxiv [Preprint]. 2023 Jan 2:2023.01.02.521806. doi: 10.1101/2023.01.02.521806. bioRxiv. 2023. PMID: 36711568 Free PMC article. Updated. Preprint.

4

Two isoleucyl tRNAs that decode synonymous codons divergently regulate breast cancer metastatic growth by controlling translation of proliferation-regulating genes.

Earnest-Noble LB, Hsu D, Chen S, Asgharian H, Nandan M, Passarelli MC, Goodarzi H, Tavazoie SF. Earnest-Noble LB, et al. Nat Cancer. 2022 Dec;3(12):1484-1497. doi: 10.1038/s43018-022-00469-9. Epub 2022 Dec 12. Nat Cancer. 2022. PMID: 36510010

5

In silico modeling of combination systemic therapy for advanced renal cell carcinoma.

Kotecha RR, Hsu DJ, Lee CH, Patil S, Voss MH. Kotecha RR, et al. Among authors: hsu dj. J Immunother Cancer. 2021 Dec;9(12):e004059. doi: 10.1136/jitc-2021-004059. J Immunother Cancer. 2021. PMID: 34952852 Free PMC article.

6

Targeting KRAS Oncogene for Patients With Colorectal Cancer: A New Step Toward Precision Medicine.

Sahin IH, Saridogan T, Ayasun R, Syed MP, Gorantla V, Malhotra M, Thomas R, Rhee J, Zhang J, Hsu D, Singhi AD, Saeed A. Sahin IH, et al. JCO Oncol Pract. 2024 May 13:OP2300787. doi: 10.1200/OP.23.00787. Online ahead of print. JCO Oncol Pract. 2024. PMID: 38739872 Review.

7

Neoadjuvant Immune Checkpoint Inhibitor Therapy for Patients With Microsatellite Instability-High Colorectal Cancer: Shedding Light on the Future.

Sahin IH, Zhang J, Saridogan T, Gorantla V, Rhree J, Malhotra M, Thomas R, Hsu D, Saeed A. Sahin IH, et al. JCO Oncol Pract. 2023 May;19(5):251-259. doi: 10.1200/OP.22.00762. Epub 2023 Mar 2. JCO Oncol Pract. 2023. PMID: 36862965

8

Cysteine substitutants emerge in lung cancer proteomes during arginine restriction.

Hsu DJ, Tavazoie SF. Hsu DJ, et al. Mol Cell. 2024 May 16;84(10):1819-1821. doi: 10.1016/j.molcel.2024.04.019. Mol Cell. 2024. PMID: 38759621

9

tinyIFD: A High-Throughput Binding Pose Refinement Workflow Through Induced-Fit Ligand Docking.

Hsu DJ, Davidson RB, Sedova A, Glaser J. Hsu DJ, et al. J Chem Inf Model. 2023 Jun 12;63(11):3438-3447. doi: 10.1021/acs.jcim.2c01530. Epub 2023 May 19. J Chem Inf Model. 2023. PMID: 37204814

10

Revealing Excited-State Trajectories on Potential Energy Surfaces with Atomic Resolution in Real Time.

Leshchev D, J S Valentine A, Kim P, Mills AW, Roy S, Chakraborty A, Biasin E, Haldrup K, Hsu DJ, Kirschner MS, Rimmerman D, Chollet M, Glownia JM, van Driel TB, Castellano FN, Li X, Chen LX. Leshchev D, et al. Among authors: hsu dj. Angew Chem Int Ed Engl. 2023 Jul 10;62(28):e202304615. doi: 10.1002/anie.202304615. Epub 2023 May 31. Angew Chem Int Ed Engl. 2023. PMID: 37114904

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page